Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
July 31, 2026 45.33M
April 30, 2026 43.37M
January 31, 2026 33.58M
October 31, 2025 25.67M
July 31, 2025 17.87M
April 30, 2025 15.54M
January 31, 2025 17.06M
October 31, 2024 11.86M
July 31, 2024 7.025M
April 30, 2024 2.245M
January 31, 2024 4.204M
October 31, 2023 3.988M
July 31, 2023 1.104M
April 30, 2023 3.854M
January 31, 2023 7.715M
October 31, 2022 7.620M
July 31, 2022 12.28M
April 30, 2022 11.25M
January 31, 2022 17.19M
October 31, 2021 22.55M
July 31, 2021 14.23M
April 30, 2021 15.19M
January 31, 2021 17.72M
October 31, 2020 20.42M
July 31, 2020 21.22M
Date Value
April 30, 2020 4.423M
January 31, 2020 6.296M
October 31, 2019 10.80M
July 31, 2019 13.59M
April 30, 2019 13.58M
January 31, 2019 19.68M
October 31, 2018 18.36M
July 31, 2018 15.35M
April 30, 2018 20.12M
January 31, 2018 25.31M
October 31, 2017 20.77M
July 31, 2017 23.16M
April 30, 2017 23.39M
January 31, 2017 23.89M
October 31, 2016 29.73M
July 31, 2016 34.16M
April 30, 2016 36.78M
January 31, 2016 36.66M
October 31, 2015 44.83M
July 31, 2015 47.64M
April 30, 2015 53.33M
January 31, 2015 57.36M
October 31, 2014 63.55M
July 31, 2014 73.91M
April 30, 2014 30.67M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Healios KK 53.98M
GNI Group Ltd. 248.83M
AnGes, Inc. 1.266M
ACADIA Pharmaceuticals, Inc. 1.307B
Alkermes Plc 1.809B

Shareholders Equity (Quarterly) Related Metrics